PT-141 for Female Sexual Dysfunction
How It Works
Activates melanocortin receptors in the brain involved in sexual arousal.
Research Evidence
FDA approved (Vyleesi) for HSDD in women. Clinical trials in both sexes.
Dosing Protocol
1-2mg subcutaneously 2-4 hours before activity. Max 8 doses per month.
Important Considerations
- !Significant nausea initially
- !Not for daily use
- !BP concerns
- !Consult healthcare provider before use
- !Quality sourcing is critical
Frequently Asked Questions
Does PT-141 work for female sexual dysfunction?
FDA approved (Vyleesi) for HSDD in women. Clinical trials in both sexes. Research level: FDA approved for HSDD in women.
How does PT-141 help with female sexual dysfunction?
Activates melanocortin receptors in the brain involved in sexual arousal.
What is the PT-141 dosage for female sexual dysfunction?
1-2mg subcutaneously 2-4 hours before activity. Max 8 doses per month.
Is PT-141 safe for female sexual dysfunction?
Key considerations: Significant nausea initially. Not for daily use. BP concerns. Consult healthcare provider before use. Quality sourcing is critical. Always consult a healthcare provider.
How long until PT-141 works for female sexual dysfunction?
Results vary by individual and condition severity. Most users report initial effects within 2-4 weeks, with full benefits developing over 8-12 weeks of consistent use.